Tele-Clinic Visits in Pediatric Marfan Patients Using Parental Echo:

Status Completed

Clinical Trial Summary

Marfan syndrome (MFS), a connective tissue disorder seen in 1 in 3,000 individuals, causes progressive aortic root dilation that can result in aortic dissection and sudden death. Clinical care focuses on monitoring the aortic root by serial echocardiography (echo) to guide medical treatment and elective aortic root surgery in a specialized clinic every 6-12 months. This monitoring protocol, coupled with surgical intervention, has doubled the median life expectancy which was previously only 32 years. However, this surveillance carries significant health care costs at >$50 million dollars/year on echos alone (at $3-4K each) in children and adolescents in the US, as well as substantial burden on families residing far from specialized centers. A clinic visit delivered to MFS patients via live-video conferencing at home (tele-visit) could shift this paradigm, if a home echo could be obtained. Here, the investigator will train parents of Pediatric Marfan patients to take echo images using a hand held device, height, weight, blood pressure, medical history, and listen to the heart of their child. Then, the investigators will ask them to take the equipment home and collect the same data at home during a tele-clinic visit, with further instruction by the study team through secure live-video conferencing.

Clinical Trial Description

In the proposed intervention, every patient (n=60) will have a tele-visit and an on-site clinic visit 1 day apart. Parents will have a 1-hour hands-on training session to acquire basic echo images on their children with the same hand-held device that will be used during the tele-visit. Tele-visit elements will include interim medical history by the parent and patient, and weight, height, vital signs, digital cardiac auscultation, and home echo (transferred via Internet for remote interpretation), all obtained by the parent. Two MFS physicians, following our routine MFS care protocol, will administer either the tele-visit or on-site clinic visit, masked to the findings of the other. Two independent echo readers will analyze home and clinic echos to measure reproducibility. ;

Study Design

Related Conditions & MeSH terms

Marfan Syndrome

Clinical Trial Details

NCT number	NCT03581682
Study type	Interventional
Source	Stanford University
Contact
Status	Completed
Phase	N/A
Start date	July 1, 2018
Completion date	August 1, 2020

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT00763893` - Study of the Efficacy of Losartan on Aortic Dilatation in Patients With Marfan Syndrome	Phase 3
Recruiting	`NCT05809323` - Marfan Syndrome Moderate Exercise Trial II	N/A
Completed	`NCT04776668` - Living With Marfan Syndrome and Your Aorta
Recruiting	`NCT01949233` - The Oxford Marfan Trial	Phase 2
Active, not recruiting	`NCT01145612` - Atenolol Versus Losartan in the Prevention of Progressive Dilation of the Aorta in Marfan Syndrome	Phase 3
Completed	`NCT00723801` - Effects of Losartan Versus Atenolol on Aortic and Cardiac Muscle Stiffness in Adults With Marfan Syndrome	Phase 3
Completed	`NCT04641325` - Marfan Syndrome Moderate Exercise Pilot	N/A
Recruiting	`NCT06257004` - Genome-wide Epistasis for Cardiovascular Severity in Marfan Study
Completed	`NCT01322165` - National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions	N/A
Recruiting	`NCT05700175` - Transcriptomic Study of Adult Population With Marfan Syndrome
Completed	`NCT00782327` - Randomized, Double-blind Study for the Evaluation of the Effect of Losartan Versus Placebo on Aortic Root Dilatation in Patients With Marfan Syndrome Under Treatment With Beta-blockers	Phase 3
Not yet recruiting	`NCT05838235` - Adapted Physical Activity Program (APA) for Effort Rehabilitation of Children and Teenagers With Marfan Syndrome	N/A
Recruiting	`NCT02148900` - Development of a Blood Test for Marfan Syndrome	N/A
Active, not recruiting	`NCT05980104` - Single-Session "Empowered Relief" Class for Marfan Syndrome and Related Conditions	N/A
Recruiting	`NCT02050113` - Complex Aortic Aneurysm Repair Using Physician Modified Endografts and Custom Made Devices	N/A
Completed	`NCT00001641` - Study of Heritable Connective Tissue Disorders	N/A
Completed	`NCT01715207` - Comparison Study of the Effect of Aliskiren Versus Negative Controls on Aortic Stiffness in Patients With Marfan Syndrome Under Treatment With Atenolol	Phase 3
Completed	`NCT05516043` - Safety and Performance of POLYTHESE® Vascular Prosthesis
Recruiting	`NCT04776681` - Living With Marfans and Your Aorta: Surgical Outcomes Study
Completed	`NCT03236571` - Cardiorespiratory and Muscular Rehabilitation of Children and Young Adults With Marfan Syndrome.	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Tele-Clinic Visits in Pediatric Marfan Patients Using Parental Echo: The Future?

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms